MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.neuroscience.2026.09.043

Медицинская библиотека · Neuroscience · 2026

Therapeutic potential of proline-rich peptide-1 (PRP-1) in counteracting amyloid-β-mediated cortical and hippocampal neurodegeneration in a rat model.

Stepanyan Harutyun, Ghorbani Hamzeh, Poghosyan Mikhail, Danielyan Margarita, Minasyan Arsen, Hunanyan Arsen, Hunanyan Naira

СтатьяПеревод пока не подготовлен

Аннотация

Alzheimer's disease (AD) is associated with amyloid β (Aβ) accumulation, neuronal metabolic dysfunction, and structural degeneration. This study compares the neurotoxic effects of Aβ25-35 and Aβ1-42 in the rat cerebral cortex and hippocampus and evaluates the neuroprotective potential of proline rich peptide 1 (PRP-1). Amyloid peptides were administered bilaterally into the lateral ventricles, followed by intramuscular PRP-1 at 0.1 mg/kg once daily for three weeks, beginning 24 h after amyloid administration. Neuronal metabolic activity was assessed by Ca2⁺ dependent acid phosphatase histochemistry with a lead capture reaction. Reaction intensity was quantified by densitometry as mean gray value (MGV), with lower values indicating greater reaction product accumulation and higher enzymatic activity. Both amyloid species disrupted cortical laminar organisation and altered enzymatic reactivity in the perikarya and dendrites of cortical pyramidal neurons, with Aβ1-42 causing greater structural disruption. When fields recorded with the same objective were compared, Aβ1-42 produced suppression of enzymatic activity in the hippocampus. CA1 pyramidal neurons showed the highest susceptibility, with confluent areas of reduced reactivity and interruption of the pyramidal cell layer. In the cortex, changes were restricted to the most severely damaged neurons. PRP-1 attenuated these alterations, preserved neuronal morphology, increased the number of reactive neurons, and enhanced enzymatic reactivity in both regions. Protection was greater in the hippocampus. These findings indicate that Aβ1-42 has greater neurotoxicity than Aβ25-35 and that PRP-1 reduces amyloid associated neuronal injury while supporting metabolic and structural recovery. PRP-1 merits further investigation as a candidate therapeutic agent for early amyloid associated neurodegeneration.

Для цитирования: Stepanyan Harutyun, Ghorbani Hamzeh, Poghosyan Mikhail, Danielyan Margarita, Minasyan Arsen, Hunanyan Arsen, Hunanyan Naira. Therapeutic potential of proline-rich peptide-1 (PRP-1) in counteracting amyloid-β-mediated cortical and hippocampal neurodegeneration in a rat model.. Neuroscience. 2026. DOI: 10.1016/j.neuroscience.2026.09.043.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.